During the past decade, SPSK2 PUM, Klinika Kardiologii conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SPSK2 PUM, Klinika Kardiologii" are "Hypertension, Pulmonary" (1 trials) and "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials). Many other conditions were trialed in "SPSK2 PUM, Klinika Kardiologii" in a lesser frequency.

Most popular intervention types in "SPSK2 PUM, Klinika Kardiologii" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FDC macitentan/tadalafil" (1 trials), "FDC of Macitentan and Tadalafil" (1 trials), "Macitentan" (1 trials), "Macitentan 10 mg" (1 trials) and "Placebo FDC" (1 trials). Other intervention names were less common.

The vast majority of trials in "SPSK2 PUM, Klinika Kardiologii" are 2 trials for "All" genders.

Currently, there are NaN active trials in "SPSK2 PUM, Klinika Kardiologii". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in SPSK2 PUM, Klinika Kardiologii, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SPSK2 PUM, Klinika Kardiologii, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".